Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Divestments: 2010-2019

  • Ironwood Pharmaceuticals' Divestments was N/A to -$4.2 million in Q1 2019 from the same period last year, while for Mar 2019 it was -$1.2 million, marking a year-over-year change of. This contributed to the annual value of -$4.2 million for FY2019, which is 48.94% up from last year.
  • As of Q1 2019, Ironwood Pharmaceuticals' Divestments stood at -$4.2 million, which was down 38.60% from -$3.0 million recorded in Q4 2018.
  • Over the past 5 years, Ironwood Pharmaceuticals' Divestments peaked at -$3.0 million during Q4 2018, and registered a low of -$4.2 million during Q1 2019.
  • Over the past 2 years, Ironwood Pharmaceuticals' median Divestments value was -$3.5 million (recorded in 2018), while the average stood at -$3.6 million.